Upvote
Downvote
VP, Program Team Leader
Share Job
- Suggest Revision
- With its proprietary FORCE platform, Dyne is developing modern oligonucleotide therapeutics that are designed toovercome limitations in delivery to muscle tissue.
- Dyne has a broad pipeline for serious muscle diseases, including clinical programs for myotonicdystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD), and a preclinical program for facioscapulohumeral muscular dystrophy (FSHD).
- Working with an experienced Program Manager and a cross-functional team, the PTL shapes the Program strategy, goals, priorities, and plans, bringing both a ‘future-orientation’ toward the ultimate goal of broad, global commercial access for patients in need, and a “pragmatic-orientation” to chart the path, mitigate risks, cultivate options, and lead through complex drug development decisions.
- Keep abreast of emerging developments regarding research and development in the fields of muscle diseases and oligonucleotide drug discovery and development
- Experience in Phase 1-3 drug development is required; product launch/early commercialization experience a strong plus
Active Job
Updated 11 days agoSimilar Job
Relevance
Active